BioNexus Gene Lab Corp (BGLC) › EPS (Diluted)BioNexus Gene Lab Corp (BGLC) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2023: $-0.172024: $-0.09$-0.092023EPS (Diluted) (USD/shares)2024Fiscal YearEPS (Diluted)Change YoY2024$-0.09+45.8%2023$-0.17—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share